TRAF5 negatively regulates TLR signaling in B lymphocytes

Area of Science:

• Immunology
• Molecular Biology
• Cell Signaling

Background:

• Toll-like receptor (TLR) signaling is crucial for innate and adaptive immunity.
• Cytoplasmic adaptor proteins TNFR-associated factor (TRAF)3 and TRAF6 are known mediators of TLR signaling.
• The precise regulatory role of other TRAF family members in TLR pathways remains incompletely understood.

Purpose of the Study:

• To investigate the function of TRAF5 in TLR signaling pathways.
• To determine whether TRAF5 plays a role in regulating B cell responses to TLR stimulation.
• To elucidate the molecular mechanisms by which TRAF5 influences TLR-mediated immune responses.

Main Methods:

• Utilized TRAF5-deficient (TRAF5(-/-)) mice and wild-type littermates.
• Stimulated B lymphocytes, macrophages, and dendritic cells with TLR ligands.
• Assessed cytokine production (IL-6, IL-12p40, IL-10, TNF-α), IgM production, cell survival, proliferation, NF-κB activation, and MAPK phosphorylation (ERK1/2, JNK).
• Performed co-immunoprecipitation assays to analyze protein-protein interactions involving TRAF5, MyD88, TAB2, and TRAF6.

Main Results:

• TRAF5(-/-) B lymphocytes exhibited significantly increased production of IL-6, IL-12p40, IL-10, TNF-α, and IgM following TLR stimulation compared to wild-type cells.
• Exogenous TRAF5 overexpression in B cells suppressed TLR-mediated cytokine and antibody production.
• TRAF5 deficiency enhanced MAPK (ERK1/2, JNK) phosphorylation but did not affect NF-κB activation, cell survival, or proliferation in B cells.
• TRAF5 negatively regulated the association between TAB2 and TRAF6 in B cells after TLR ligation.
• TRAF5's regulatory role in TLR signaling was cell-specific, with less pronounced effects observed in macrophages and dendritic cells.

Conclusions:

• TRAF5 functions as a novel negative regulator of TLR signaling, particularly in B lymphocytes.
• TRAF5 modulates TLR-induced immune responses by influencing MAPK activation and protein complex formation.
• These findings reveal a new layer of complexity in TLR signal transduction and identify TRAF5 as a potential therapeutic target for immune modulation.